In Lincolnshire, investment has been made to increase access to osteoporosis diagnosis and secondary fracture prevention. There are three dual-energy X-ray absorptiometry (DEXA) scanners serving the county, and an additional scanner at Grantham, operational since March 2024, which has helped to reduce waiting times across the county by supporting patients to typically be seen within two to three weeks.

Alongside increased diagnostic capacity, the local service plans to provide bone mineral density scanning, bone health advice, therapy-compliance support, and bone health and falls assessments. With ongoing service development, the fracture liaison element aims to support patients by telephone or through outpatient clinics, with the aim of identifying people at risk following a fragility fracture and reducing the likelihood of further fractures.

At the University Hospitals of Derby and Burton (UHDB), osteoporosis care is provided through the Osteoporosis and Fracture Liaison Service. The service is delivered by a multidisciplinary team comprising four consultant specialists and 3.9 whole-time equivalent clinical nurse specialists, who run both consultant-led and nurse-led clinics. Referrals are accepted from general practices, hospital specialties, and orthopaedic fracture clinics, ensuring patients can access specialist assessment following a fracture or where osteoporosis is suspected. Dedicated clinics are provided across the trust, including a monthly clinic at Queen's Hospital Burton.

The service offers comprehensive diagnostic and treatment pathways, with DEXA bone density scanners available at multiple sites to support timely diagnosis. Once diagnosed, patients can access osteoporosis treatments through medical day case units at both hospital sites. When staffing allows, the team also delivers patient education sessions in community settings to help people better understand their condition and reduce their risk of future fractures.

UHDB has recently strengthened its diagnostic capability through the Department’s funding for a new state-of-the-art DEXA scanner for Queen's Hospital Burton. The trust has recently strengthened diagnostic capacity through the installation of a new DEXA scanner as part of the community diagnostic centre (CDC) phase 2 programme at Walton Hospital. This additional capacity is helping to improve access to diagnostic testing and support earlier diagnosis and treatment.

Performance data for July 2026 showed that 89% of patients received their DEXA scan within six weeks, helping ensure timely assessment and reducing waiting times for patients requiring investigation of osteoporosis and bone health conditions.

There is a hospital service for Mid-Nottinghamshire provided by Sherwood Forest Hospitals. This provides the diagnosis and initial treatment following fragility fracture and the more complex ongoing treatment, with primary care providing less complex ongoing treatment. In the city and south, Nottingham University Hospitals provide the initial diagnosis following a fragility fracture, and the more complex treatment is provided by Nottingham CityCare in the community, with primary care providing a service for less complex care.

The Government is committed to attracting more international visitors to the UK and works closely with VisitBritain, the national tourist board, to showcase Britain as a premier holiday destination.

To capitalise on the growing trend of screen tourism and drive inbound visits, VisitBritain launched its global "Starring Great Britain" campaign in January 2025. This initiative leverages the UK’s rich film and television heritage to inspire travelers to explore diverse locations across the UK, from the Houses of Parliament and Lyme Park to the Lake District and the Highlands. The launch was supported by a wider advertising campaign across the UK’s largest and most valuable inbound visitor markets including Australia, the Gulf Co-operation Council (GCC) countries, France, Germany and the USA.

The Government is committed to supporting the sector through the forthcoming Visitor Economy Growth Strategy, which will set out a long term plan to attract more international visitors to the UK, boost value, and deliver sustainable growth across regional visitor economies.

The Department will invest approximately £1.8 billion in 2026/27 through the National Institute for Health and Care Research (NIHR), which funds and supports high-quality health, public health, and social care research across the National Health Service, academia, and industry through open, competitive funding and independent expert review.

The Department is continuing to strengthen the NIHR’s contribution to the Government’s Health and Growth Missions, the 10-Year Health Plan, and the Life Sciences Sector Plan by supporting research into prevention and long-term conditions, accelerating innovation adoption, improving commercial clinical trial delivery, and strengthening research delivery capacity across the health and care system.

Recent developments include the introduction of the NIHR Innovation Catalyst, a new national Research Delivery Network funding model, and the establishment of the NIHR Council to provide independent advice and assurance. The Department also continues to oversee the NIHR’s performance, delivery, and value for money through established governance and contractual arrangements, while the OneNIHR agenda is improving coordination, consistency, and efficiency across the organisation to ensure it remains well placed to deliver against Government priorities.

The NHS App is able to integrate with all general practice core clinical systems, most online consultation solutions, and the majority of patient messaging platforms. It is also integrated with all but two acute trusts, all specialist trusts, and several mental health and community trust solutions for appointment management. As part of delivering the 10-Year Health Plan, NHS England is reviewing the standards and capabilities required across primary and secondary care digital solutions to support more joined-up care through the NHS App as a single point of access.

NHS England has launched a Digital Pathways Registry, which will raise the baseline standards expected of digital solutions in primary care. This includes strengthened requirements for interoperability, common data standards, and integration with national services such as the NHS App, supporting a more consistent and connected digital experience for patients and professionals.

Improving outcomes for cancer patients is a priority for the Government. The National Cancer Plan sets out a clear ambition to improve early diagnosis and survival across all cancer types, including leukaemia and other blood cancers.

The National Cancer Plan recognises that blood cancers are harder to measure through traditional early diagnosis metrics because they cannot be staged in the same way as other cancers. As a result, NHS England will publish regular data on cancers diagnosed through emergency presentations as a proxy measure for late diagnosis. This will help identify variation and encourage systems to focus on earlier diagnosis of blood cancers, including leukaemia, and other rarer cancers.

In addition, the Department and NHS England are supporting development of a suspected haematological cancer timed diagnostic pathway being led by Leukaemia UK, Lymphoma Action, and Myeloma UK. This guidance is intended to support National Health Service organisations to reduce diagnostic delays, improve consistency of care, and help more patients receive a diagnosis within 28 days of referral under the Faster Diagnosis Standard. Publication is expected later this year.

Progress against the National Cancer Plan's commitments for rare and less common cancers will be overseen through the National Cancer Board, which is responsible for tracking delivery and monitoring impact. To strengthen accountability, the Government will appoint a National Clinical Lead for Rare Cancers who will provide independent clinical advice and support monitoring of progress against the plan's commitments. The Department will continue to publish cancer performance and outcomes data, and ministers will provide regular updates on delivery of the plan.

Improving outcomes for cancer patients is a priority for the Government. The National Cancer Plan sets out a clear ambition to improve early diagnosis and survival across all cancer types, including leukaemia and other blood cancers.

The National Cancer Plan recognises that blood cancers are harder to measure through traditional early diagnosis metrics because they cannot be staged in the same way as other cancers. As a result, NHS England will publish regular data on cancers diagnosed through emergency presentations as a proxy measure for late diagnosis. This will help identify variation and encourage systems to focus on earlier diagnosis of blood cancers, including leukaemia, and other rarer cancers.

In addition, the Department and NHS England are supporting development of a suspected haematological cancer timed diagnostic pathway being led by Leukaemia UK, Lymphoma Action, and Myeloma UK. This guidance is intended to support National Health Service organisations to reduce diagnostic delays, improve consistency of care, and help more patients receive a diagnosis within 28 days of referral under the Faster Diagnosis Standard. Publication is expected later this year.

Progress against the National Cancer Plan's commitments for rare and less common cancers will be overseen through the National Cancer Board, which is responsible for tracking delivery and monitoring impact. To strengthen accountability, the Government will appoint a National Clinical Lead for Rare Cancers who will provide independent clinical advice and support monitoring of progress against the plan's commitments. The Department will continue to publish cancer performance and outcomes data, and ministers will provide regular updates on delivery of the plan.

The Government published an updated assessment in October 2024 of the impact of introducing Extended Producer Responsibility for packaging (pEPR) on packaging producers as a whole. The assessment did not provide separate estimates for breweries, pubs or hospitality businesses, or disaggregate impacts at a local level.

The Government is aware of concerns about the classification of packaging that is disposed of through commercial waste streams, including in hospitality settings. Defra continues to work on this issue and that includes working closely with the brewing, hospitality and wider packaging sectors.

I refer the Hon Member to the answer provided on 17 July 2026 in response to Question 18279.

We have invested over £1 billion in homelessness and rough sleeping services this year, which can be used flexibly to address a range of local needs, including support for young people. The Spending Review protects this record level of investment to tackle homelessness and rough sleeping for the next three years.

For young people ready to live independently, we are delivering the biggest increase in social and affordable housebuilding in a generation, backed by the £39 billion Social and Affordable Homes Programme. We are also reforming the private rented sector to give more security to tenants, bringing an end to rental bidding, outlawing discrimination against prospective tenants with children or those who receive social security benefits; and preventing landlords from demanding large amounts of rent in advance.

An assessment of the impacts of decisions taken by the Chancellor at the Budget is published within the relevant Tax Impact and Information Note (TIIN). The TIINs for the inflation-linked uprating to alcohol duty announced at Autumn Budget 2024 and 2025 are available here:

Alcohol Duty uprating - GOV.UK

Alcohol Duty uprating - GOV.UK

VAT is a broad-based tax on consumption, and the 20 per cent standard rate applies to most goods and services. Exceptions to the standard rate are limited and must be balanced against their impact on the public finances.

HMRC estimates that the cost of changing the 20 per cent Standard Rate of VAT on all accommodation and food and beverage services to the Reduced Rate of 5 per cent would be around £17 billion in 2026-27, rising to £19.5 billion in 2030-31.

An assessment of the impacts of decisions taken by the Chancellor at the Budget is published within the relevant Tax Impact and Information Note (TIIN). The TIINs for the inflation-linked uprating to alcohol duty announced at Autumn Budget 2024 and 2025 are available here:

Alcohol Duty uprating - GOV.UK

Alcohol Duty uprating - GOV.UK

The Government is aware some European countries apply different VAT rates to certain goods and services, reflecting different tax systems, policy choices and wider fiscal contexts.

VAT is a broad-based tax on consumption, and the 20 per cent standard rate applies to most goods and services in the UK. Reduced rates of VAT come at a significant cost to the Exchequer, reduce the revenue available for vital public services, and must represent value for money for the taxpayer.

Further to the answer of 4 March in response to Question 114118, the Paediatric Hearing Services Improvement Programme has had a particular focus on improving the quality, outcomes and governance of paediatric audiology services, working alongside National Health Service regions and integrated care boards. Further information is available at the following link:

https://www.england.nhs.uk/long-read/paediatric-hearing-services-improvement-programme-operational-guidance/

As a result, NHS England is refreshing commissioning guidance to ensure it supports safe, effective and high-quality services for deaf children and their families.